Evidence map›Paper›PMID 38378588›Full record

ArticleBMJ case reports2024

Response to sorafenib in a locally advanced oncocytic cell carcinoma of the thyroid.

Andres Pereira, Diana Parra, Mauricio Alvarez, Oswaldo Rincon

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Diagnosis and management of brain metastasis from thyroid cancer.Endocrine oncology (Bristol, England) · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Andres PereiraFacultad de Medicina y Ciencias de la Salud, Universidad Militar Nueva Granada, Bogotá, Cundinamarca, Colombia.
Diana ParraFacultad de Medicina y Ciencias de la Salud, Universidad Militar Nueva Granada, Bogotá, Cundinamarca, Colombia.
Mauricio AlvarezHospital Militar Central, Bogotá, Colombia drmauricioalvareza@gmail.com.
Oswaldo RinconHospital Militar Central, Bogotá, Colombia.
Hospital Militar Central · CODepartamento de Salud · ESMilitary University Nueva Granada · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the case of a female patient in her late 70s, diagnosed with widely invasive oncocytic cell carcinoma, with extrathyroidal extension, infiltration into the extrathyroidal muscle, involvement of the sternohyoid muscle and infiltration into the external muscle fibres of the oesophagus. Over the following year, metastases were documented in the lungs, bones and brain. Additionally, there was progression of the locally advanced lesion involving the airway and upper gastrointestinal tract. After considering iodine refractoriness, treatment with sorafenib was initiated. Notably, regression of the locoregional lesion at the cervical level was observed following treatment with the multikinase inhibitor.

Indexed as

AdenocarcinomaThyroid NeoplasmsFemaleHumansNiacinamidePhenylurea CompoundsSorafenibThyroid Cancer, PapillaryNiacinamidePhenylurea CompoundsSorafenibHead and neck cancerThyroid diseaseTyrosine Kinase Inhibitor

Identifiers

PMID38378588
PMCPMC10882407
OpenAlexW4392002747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.